Zymeworks Inc. (ZYME)

Zymeworks’ revenue fell 90.6% year over year to about $4.6 million in the second fiscal quarter of 2026, reported August 6, 2026, while results were mixed versus consensus as revenue topped expectations but EPS trailed. Revenue of $4.6 million topped the $4.5 million estimate, +1.2%, and was down from $48.7 million a year ago, with gross profit also roughly $4.6 million. EPS came in at -$0.62, trailed the -$0.57 estimate by -$0.05, and compared with $0.03 a year ago, as the company posted an operating loss of about $42.2 million and a net loss of roughly $45.0 million versus net income of $2.3 million a year ago. Consensus for the next period calls for EPS of $2.42 on revenue of $231.9 million.